5251 - 5300 of 9145 Results
Title
Year
- Functional ataxia in a specialized ataxia center2024RESTRICTEDTitle: Functional ataxia in a specialized ataxia centerJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 120Issue #:Start Page: 106006End Page: 106006Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106006Citation Count: 0
-
OPENTitle: Combating Parkinson’s disease-associated toxicity by modulating proteostasisJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 114Issue #: 5Start Page: 803End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1620082114Best OA location URL: https://www.pnas.org/content/pnas/114/5/803.full.pdfCitation Count: 6
-
OPENTitle: Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interactionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 72End Page: 76Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.07.007Best OA location URL: https://zenodo.org/record/3421671Citation Count: 28
-
RESTRICTEDTitle: Dysphagia Is Associated with Incident Non‐Motor Symptoms in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 12Issue #: 11Start Page: 1909End Page: 1924Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.70297Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12625101/Citation Count: 0
-
OPENTitle: A molecular glue for PRKN/parkinJournal Name: AutophagyPublisher: Informa UK LimitedVol: 21Issue #: 3Start Page: 689End Page: 690Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2024.2443232Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11849950/pdf/KAUP_21_2443232.pdfCitation Count: 2
- Evidence for topographic guidance of dopaminergic axons by differential Netrin-1 expression in the striatum2014RESTRICTEDTitle: Evidence for topographic guidance of dopaminergic axons by differential Netrin-1 expression in the striatumJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 61Issue #:Start Page: 85End Page: 96Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2014.05.003Citation Count: 36
- Gender disparities in deep brain stimulation surgery for Parkinson disease and essential tremor2023OPENTitle: Gender disparities in deep brain stimulation surgery for Parkinson disease and essential tremorJournal Name: Deep Brain StimulationPublisher: Elsevier BVVol: 1Issue #:Start Page: 26End Page: 33Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jdbs.2023.04.001Best OA location URL: https://doi.org/10.1016/j.jdbs.2023.04.001Citation Count: 14
-
OPENTitle: Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 1005Issue #:Start Page: 178031End Page: 178031Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ejphar.2025.178031Best OA location URL: https://doi.org/10.1016/j.ejphar.2025.178031Citation Count: 0
-
OPENTitle: Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies TreatmentJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 3Start Page: 255End Page: 258Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12611Citation Count: 7
- A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro2015RESTRICTEDTitle: A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitroJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 607Issue #:Start Page: 83End Page: 89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.09.015Citation Count: 51
- Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease2018RESTRICTEDTitle: Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 1Start Page: 688End Page: 701Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1109-6Citation Count: 66
-
OPENTitle: Longitudinal brain morphometry in Parkinson's disease clinical subtypes: Distinct signatures forecast behavioral change within subtypesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 142Issue #:Start Page: 108141End Page: 108141Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108141Best OA location URL: https://www.prd-journal.com/article/S1353-8020(25)00890-9/pdfCitation Count: 0
- Insufficient effect of deep brain stimulation in a patient with KCNN2-associated myoclonus-dystonia2025RESTRICTEDTitle: Insufficient effect of deep brain stimulation in a patient with KCNN2-associated myoclonus-dystoniaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 131Issue #:Start Page: 107260End Page: 107260Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107260Citation Count: 6
-
OPENTitle: Reliability of remote video ratings of the scale for assessment and rating of ataxiaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107278End Page: 107278Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107278Best OA location URL: https://www.prd-journal.com/article/S1353-8020(25)00019-7/pdfCitation Count: 4
- Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study2017RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
-
OPENTitle: Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonistsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 175Issue #: 5Start Page: 782End Page: 796Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.14123Best OA location URL: https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14123Citation Count: 22
- History of high household pesticide use and Parkinson's disease in Brazil2023RESTRICTEDTitle: History of high household pesticide use and Parkinson's disease in BrazilJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 113Issue #:Start Page: 105493End Page: 105493Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105493Citation Count: 11
-
OPENTitle: A role for the autophagy receptor NBR1 in the degradation of tau aggregatesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 214Issue #:Start Page: 107060End Page: 107060Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107060Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107060Citation Count: 3
- A pilot study of human brain tissue post-magnetic resonance imaging: Information from the National Deep Brain Stimulation Brain Tissue Network (DBS-BTN)2010RESTRICTEDTitle: A pilot study of human brain tissue post-magnetic resonance imaging: Information from the National Deep Brain Stimulation Brain Tissue Network (DBS-BTN)Journal Name: NeuroImagePublisher: Elsevier BVVol: 54Issue #:Start Page: S233End Page: S237Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2010.09.014Citation Count: 10
- A turn for the worse: Turning performance in Parkinson's disease and Essential tremor2019RESTRICTEDTitle: A turn for the worse: Turning performance in Parkinson's disease and Essential tremorJournal Name: Clinical BiomechanicsPublisher: Elsevier BVVol: 70Issue #:Start Page: 245End Page: 248Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinbiomech.2019.09.008Citation Count: 7
-
OPENTitle: 4R-cembranoid protects neuronal cells from oxygen–glucose deprivation by modulating microglial cell activationJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 179Issue #:Start Page: 74End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainresbull.2021.12.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8849140Citation Count: 9
-
OPENTitle: Clinical and Neuropathological Features Associated With Loss of RAB39BJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 687End Page: 693Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1002/mds.27951Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27951Citation Count: 22
-
OPENTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 84
- Reply to: “Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example”2025RESTRICTEDTitle: Reply to: “Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example”Journal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 7Start Page: 1444End Page: 1445Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.30247Citation Count: 1
-
OPENTitle: The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100177End Page: 100177Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100177Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100177Citation Count: 3
- 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's disease2018RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 13
- SERIAL‐ORDER recall in working memory across the cognitive spectrum of Parkinson’s disease and neuroimaging correlates2020RESTRICTEDTitle: SERIAL‐ORDER recall in working memory across the cognitive spectrum of Parkinson’s disease and neuroimaging correlatesJournal Name: Journal of NeuropsychologyPublisher: WileyVol: 15Issue #: 1Start Page: 88End Page: 111Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnp.12208Citation Count: 11
-
OPENTitle: Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein FibrilsJournal Name: NeurosciencePublisher: Elsevier BVVol: 437Issue #:Start Page: 64End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.04.032Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7510511Citation Count: 24
- Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future Studies2021RESTRICTEDTitle: Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future StudiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1731End Page: 1732Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28637Citation Count: 8
-
OPENTitle: Cultural and systemic barriers in Parkinson's disease diagnosis, treatment, and research participation among Asian Americans: A qualitative studyJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 3Start Page: 460End Page: 471Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261429265Best OA location URL: https://doi.org/10.1177/1877718x261429265Citation Count: 0
-
OPENTitle: Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFADmice, an animal model of Alzheimer's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 132Issue #: 2Start Page: 254End Page: 262Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12935Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12935Citation Count: 45
- Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers2019OPENTitle: Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.038Best OA location URL: http://hdl.handle.net/10810/64481Citation Count: 21
-
OPENTitle: DARQ: Deep learning of quality control for stereotaxic registration of human brain MRI to the T1w MNI-ICBM 152 templateJournal Name: NeuroImagePublisher: Elsevier BVVol: 257Issue #:Start Page: 119266End Page: 119266Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuroimage.2022.119266Best OA location URL: https://doi.org/10.1016/j.neuroimage.2022.119266Citation Count: 17
-
OPENTitle: The effect of Apolipoprotein E4 on cognitive function in Parkinson’s disease: A structural MRI study in the PPMI cohortJournal Name: PLOS OnePublisher: Public Library of Science (PLoS)Vol: 21Issue #: 1Start Page: e0341240End Page: e0341240Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0341240Best OA location URL: https://doi.org/10.1371/journal.pone.0341240Citation Count: 0
-
OPENTitle: Development and validation of a sensitive HPLC-HESI-MS/MS method for quantitative determination of bitopertin in rat and marmoset plasmaJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 4Issue #:Start Page: 2End Page: 2Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.12688/mniopenres.12850.1Best OA location URL: https://mniopenresearch.org/articles/4-2/v1/pdfCitation Count: 2
-
OPENTitle: Differential protein–protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathwaysJournal Name: Journal of NeurochemistryPublisher: WileyVol: 131Issue #: 2Start Page: 239End Page: 250Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12798Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12798?download=trueCitation Count: 52
- P4‐308: CSF α‐synuclein, BETA‐AMYLOID 1–42 and tau proteins: Relationship to clinical parameters in early Parkinson's disease2012RESTRICTEDTitle: P4‐308: CSF α‐synuclein, BETA‐AMYLOID 1–42 and tau proteins: Relationship to clinical parameters in early Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_21Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.08.089Citation Count: 0
-
OPENTitle: Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease studyJournal Name: Contemporary Clinical TrialsPublisher: Elsevier BVVol: 115Issue #:Start Page: 106713End Page: 106713Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cct.2022.106713Best OA location URL: https://doi.org/10.1016/j.cct.2022.106713Citation Count: 21
- Real-Time Evaluation of Magnetoelectric Nanoparticle-Induced Neurostimulation in Ex Vivo Human Brain2026OPENTitle: Real-Time Evaluation of Magnetoelectric Nanoparticle-Induced Neurostimulation in Ex Vivo Human BrainJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurom.2026.04.012Best OA location URL: https://www.neuromodulationjournal.org/article/S1094-7159(26)00110-8/pdfCitation Count: 0
-
OPENTitle: Color discrimination errors associate with axial motor impairments in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 6Start Page: 864End Page: 869Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12527Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12527Citation Count: 9
-
OPENTitle: RETRACTED: Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain DisordersJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 24Issue #: 4Start Page: 746End Page: 758Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/mt.2015.232Best OA location URL: http://www.cell.com/article/S1525001616309984/pdfCitation Count: 41
-
OPENTitle: Targeting short-chain fatty acids receptors signalling for neurological disorders treatmentJournal Name: Exploration of Neuroprotective TherapyPublisher: Open Exploration PublishingVol:Issue #:Start Page: 100End Page: 107Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.37349/ent.2024.00073Best OA location URL: https://www.explorationpub.com/uploads/Article/A100473/100473.pdfCitation Count: 9
- Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress2018RESTRICTEDTitle: Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stressJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 144Issue #:Start Page: 19End Page: 28Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.10.013Citation Count: 60
-
OPENTitle: Olfaction in Neuropathologically Defined Progressive Supranuclear PalsyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1700End Page: 1704Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28568Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9972484Citation Count: 19
- Smell status in functional movement disorders: New clues for diagnosis and underlying mechanisms2019OPENTitle: Smell status in functional movement disorders: New clues for diagnosis and underlying mechanismsJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 177Issue #:Start Page: 68End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2018.12.017Best OA location URL: https://repositorio.udes.edu.co/handle/001/3108Citation Count: 4
-
OPENTitle: Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale‐2 in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 2Start Page: 285End Page: 291Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27575Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6532623Citation Count: 19
- Shear-sensitive clustering of nanoparticles and their protein corona composition govern α-synuclein aggregation2026RESTRICTEDTitle: Shear-sensitive clustering of nanoparticles and their protein corona composition govern α-synuclein aggregationJournal Name: Environmental Science: NanoPublisher: Royal Society of Chemistry (RSC)Vol: 13Issue #: 6Start Page: 2795End Page: 2816Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/d5en00635jCitation Count: 0
-
OPENTitle: Protein synthesis is suppressed in sporadic and familial Parkinson’s disease by LRRK2Journal Name: The FASEB JournalPublisher: WileyVol: 34Issue #: 11Start Page: 14217End Page: 14233Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1096/fj.202001046rBest OA location URL: https://faseb.onlinelibrary.wiley.com/doi/pdfdirect/10.1096/fj.202001046RCitation Count: 37
-
OPENTitle: Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 54Issue #:Start Page: 110End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.003Best OA location URL: https://zenodo.org/record/3832125Citation Count: 36
- Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate2020OPENTitle: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidateJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 138Issue #:Start Page: 104789End Page: 104789Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104789Citation Count: 34